Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/1275
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMolassiotis, Alexanderen_UK
dc.contributor.authorScott, Juliaen_UK
dc.contributor.authorKearney, Noraen_UK
dc.contributor.authorPud, Doriten_UK
dc.contributor.authorMagri, Miriamen_UK
dc.contributor.authorSelvekerova, Sarkaen_UK
dc.contributor.authorBruyns, Ingriden_UK
dc.contributor.authorFernandez-Ortega, Pazen_UK
dc.contributor.authorPanteli, Vassilikien_UK
dc.contributor.authorMargulies, Anitaen_UK
dc.contributor.authorGudmundsdottir, Gudbjorgen_UK
dc.contributor.authorMilovics, Ljiljanaen_UK
dc.contributor.authorOzden, Gultenen_UK
dc.contributor.authorPlatin, Nurgunen_UK
dc.contributor.authorPatiraki, Elisabethen_UK
dc.date.accessioned2017-09-22T22:18:46Z-
dc.date.available2017-09-22T22:18:46Zen_UK
dc.date.issued2006-03en_UK
dc.identifier.urihttp://hdl.handle.net/1893/1275-
dc.description.abstractComplementary and alternative medicine (CAM) has gained popularity among cancer patients in the past years. For this study, CAM includes any group of health care systems, practices or products that are not considered to be part of conventional medicine at present (National Center for Complementary and Alternative Medicine). The present study assessed patterns of CAM use in breast cancer patients in Europe. The study used a descriptive cross-sectional design, and data were collected through a 27-item questionnaire. The sample, which was part of a larger study, consisted of 282 breast cancer patients from 11 countries in Europe. Among participants, 44.7% used CAM since their diagnosis of cancer. The most common therapies used included herbal medicine (46.4%) and medicinal teas, relaxation techniques, spiritual therapies, homeopathy and vitamins/minerals. Younger patients with higher education and who had received combination treatments for their cancer in the past were more likely to use CAM. High levels of satisfaction were reported, with only 6.5% of the women reporting no benefits from the CAM used. Main sources of information about CAM were mostly friends/family and the media. Findings suggested that a high proportion of breast cancer patients used CAM, which may have implications for the clinical management of these patients.en_UK
dc.language.isoenen_UK
dc.publisherSpringeren_UK
dc.relationMolassiotis A, Scott J, Kearney N, Pud D, Magri M, Selvekerova S, Bruyns I, Fernandez-Ortega P, Panteli V, Margulies A, Gudmundsdottir G, Milovics L, Ozden G, Platin N & Patiraki E (2006) Complementary and alternative medicine use in breast cancer patients in Europe. Supportive Care in Cancer, 14 (3), pp. 260-267. https://doi.org/10.1007/s00520-005-0883-7en_UK
dc.rightsThe publisher does not allow this work to be made publicly available in this Repository. Please use the Request a Copy feature at the foot of the Repository record to request a copy directly from the author; you can only request a copy if you wish to use this work for your own research or private study.en_UK
dc.rights.urihttp://www.rioxx.net/licenses/under-embargo-all-rights-reserveden_UK
dc.subjectComplementary medicineen_UK
dc.subjectAlternative medicineen_UK
dc.subjectcomplementary therapiesen_UK
dc.subjectBreast canceren_UK
dc.subjectEuropeen_UK
dc.subjectAlternative medicineen_UK
dc.subjectComplementary Therapiesen_UK
dc.subjectBreast Cancer Alternative treatmenten_UK
dc.subjectCancer Patients Europeen_UK
dc.titleComplementary and alternative medicine use in breast cancer patients in Europeen_UK
dc.typeJournal Articleen_UK
dc.rights.embargodate3000-01-01en_UK
dc.rights.embargoreason[Molassiotis - Complementary and alternative medicine use in breast cancer patients in Europe.pdf] We would like to delay access to this to article and request that the 'Request from author' option be added to this paper. The publisher does not allow this work to be made publicly available in this Repository therefore there is an embargo on the full text of the work.en_UK
dc.identifier.doi10.1007/s00520-005-0883-7en_UK
dc.identifier.pmid16143871en_UK
dc.citation.jtitleSupportive Care in Canceren_UK
dc.citation.issn1433-7339en_UK
dc.citation.issn0941-4355en_UK
dc.citation.volume14en_UK
dc.citation.issue3en_UK
dc.citation.spage260en_UK
dc.citation.epage267en_UK
dc.citation.publicationstatusPublisheden_UK
dc.citation.peerreviewedRefereeden_UK
dc.type.statusVoR - Version of Recorden_UK
dc.author.emailnora.kearney@stir.ac.uken_UK
dc.contributor.affiliationUniversity of Manchesteren_UK
dc.contributor.affiliationHS UG Regulated - Stirling - LEGACYen_UK
dc.contributor.affiliationCancer Care Research Centre - LEGACYen_UK
dc.contributor.affiliationUniversity of Haifaen_UK
dc.contributor.affiliationUniversity of Milanen_UK
dc.contributor.affiliationMasaryk Memorial Cancer Instituteen_UK
dc.contributor.affiliationBelgian Society of Oncology Nursingen_UK
dc.contributor.affiliationInstitut CatalĂ  Oncologia ICOen_UK
dc.contributor.affiliationGreek Oncology Nursing Societyen_UK
dc.contributor.affiliationUniversity Hospital Zurichen_UK
dc.contributor.affiliationDepartment of Oncology, Landspitalien_UK
dc.contributor.affiliationInstitute for Oncology and Radiology, Serbiaen_UK
dc.contributor.affiliationGazi University Hospitalen_UK
dc.contributor.affiliationKoc Universityen_UK
dc.contributor.affiliationGreek Oncology Nursing Societyen_UK
dc.identifier.isiWOS:000235369700008en_UK
dc.identifier.scopusid2-s2.0-32644484725en_UK
dc.identifier.wtid814610en_UK
dc.date.accepted2005-08-17en_UK
dcterms.dateAccepted2005-08-17en_UK
dc.date.filedepositdate2009-06-02en_UK
rioxxterms.typeJournal Article/Reviewen_UK
rioxxterms.versionVoRen_UK
local.rioxx.authorMolassiotis, Alexander|en_UK
local.rioxx.authorScott, Julia|en_UK
local.rioxx.authorKearney, Nora|en_UK
local.rioxx.authorPud, Dorit|en_UK
local.rioxx.authorMagri, Miriam|en_UK
local.rioxx.authorSelvekerova, Sarka|en_UK
local.rioxx.authorBruyns, Ingrid|en_UK
local.rioxx.authorFernandez-Ortega, Paz|en_UK
local.rioxx.authorPanteli, Vassiliki|en_UK
local.rioxx.authorMargulies, Anita|en_UK
local.rioxx.authorGudmundsdottir, Gudbjorg|en_UK
local.rioxx.authorMilovics, Ljiljana|en_UK
local.rioxx.authorOzden, Gulten|en_UK
local.rioxx.authorPlatin, Nurgun|en_UK
local.rioxx.authorPatiraki, Elisabeth|en_UK
local.rioxx.projectInternal Project|University of Stirling|https://isni.org/isni/0000000122484331en_UK
local.rioxx.freetoreaddate3000-01-01en_UK
local.rioxx.licencehttp://www.rioxx.net/licenses/under-embargo-all-rights-reserved||en_UK
local.rioxx.filenameMolassiotis - Complementary and alternative medicine use in breast cancer patients in Europe.pdfen_UK
local.rioxx.filecount1en_UK
local.rioxx.source0941-4355en_UK
Appears in Collections:Faculty of Health Sciences and Sport Journal Articles

Files in This Item:
File Description SizeFormat 
Molassiotis - Complementary and alternative medicine use in breast cancer patients in Europe.pdfFulltext - Published Version109.19 kBAdobe PDFUnder Embargo until 3000-01-01    Request a copy


This item is protected by original copyright



Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.